CACNA1A and mucopolysaccharidosis: Preliminary studies in our laboratory revealed that the recombinant Mhp P97R1P46P42 chimeric antigen has good immunogenicity in both mouse and piglet models and can be used as a candidate antigen for the genetically engineered subunit vaccine against MPS [27,28].